MedTrace Logo

Chinese American Cancer Survivors Writing Study

NCT05456100 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2025-12-09

No results posted yet for this study

Summary

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Conditions

Interventions

BEHAVIORAL

Expressive Helping

Expressive helping involves a combination of emotional disclosure and peer support writing completed over four weeks.

BEHAVIORAL

Expressive Writing

Expressive writing involves emotional disclosure writing over four weeks.

BEHAVIORAL

Factual Writing

Factual writing involves writing facts about cancer treatment and experiences over four weeks.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • New York University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05456100 on ClinicalTrials.gov